Cargando…
Abnormal DNA methylation may contribute to the progression of osteosarcoma
The identification of optimal methylation biomarkers to achieve maximum diagnostic ability remains a challenge. The present study aimed to elucidate the potential molecular mechanisms underlying osteosarcoma (OS) using DNA methylation analysis. Based on the GSE36002 dataset obtained from the Gene Ex...
Autores principales: | Chen, Xiao-Gang, Ma, Liang, Xu, Jia-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780126/ https://www.ncbi.nlm.nih.gov/pubmed/29115427 http://dx.doi.org/10.3892/mmr.2017.7869 |
Ejemplares similares
-
An integrative analysis of DNA methylation in osteosarcoma
por: Xu, Jie, et al.
Publicado: (2017) -
Correlation study of DNA methylation of WNT6 gene with osteosarcoma in children
por: Li, Li, et al.
Publicado: (2017) -
The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma
por: Sun, Xin, et al.
Publicado: (2018) -
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms
por: Zhou, Ping, et al.
Publicado: (2023) -
High level of RNF187 contributes to the progression and drug resistance of osteosarcoma
por: Wan, Wen-Bing, et al.
Publicado: (2020)